The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Anti-diabetic activity of insulin-degrading enzyme inhibitors mediated by multiple hormones
Open accessAbstract
Despite decades of speculation that inhibiting endogenous insulin degradation might treat type-2 diabetes, and the identification of IDE (insulin-degrading enzyme) as a diabetes susceptibility gene, the relationship between the activity of the zinc metalloprotein IDE and glucose homeostasis remains unclear. Although Ide–/– mice have elevated insulin levels, they exhibit impaired, rather than improved, glucose tolerance that may arise from compensatory insulin signalling dysfunction. IDE inhibitors that are active in vivo are therefore needed to elucidate IDE’s physiological roles and to determine its potential to serve as a target for the treatment of diabetes. Here we report the discovery of a physiologically active IDE inhibitor identified from a DNA-templated macrocycle library. An X-ray structure of the macrocycle bound to IDE reveals that it engages a binding pocket away from the catalytic site, which explains its remarkable selectivity. Treatment of lean and obese mice with this inhibitor shows that IDE regulates the abundance and signalling of glucagon and amylin, in addition to that of insulin. Under physiological conditions that augment insulin and amylin levels, such as oral glucose administration, acute IDE inhibition leads to substantially improved glucose tolerance and slower gastric emptying. These findings demonstrate the feasibility of modulating IDE activity as a new therapeutic strategy to treat type-2 diabetes and expand our understanding of the roles of IDE in glucose and hormone regulation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A genome-wide association study identifies novel risk loci for type 2 diabetes
Sladek, R., Rocheleau, G., Rung, J., Dina, C., Shen, L., Serre, D., Boutin, P., Vincent, D., Belisle, A., Hadjadj, S., et al. (2007) · Nature · doi:10.1038/nature05616 · Cited by 2,993
The biology of incretin hormones
Drucker, D. J. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.004 · Cited by 2,210
Replication of Genome-Wide Association Signals in UK Samples Reveals Risk Loci for Type 2 Diabetes
Zeggini, E., Weedon, M. N., Lindgren, C. M., Frayling, T. M., Elliott, K. S., Lango, H., Timpson, N. J., Perry, J. R. B., Rayner, N. W., Freathy, R. M., et al. (2007) · Science · doi:10.1126/science.1142364 · Cited by 2,194
Farris, W., Mansourian, S., Chang, Y., Lindsley, L., Eckman, E. A., Frosch, M. P., Eckman, C. B., Tanzi, R. E., Selkoe, D. J., & Guénette, S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0230450100 · Cited by 1,286
Winzell, M. S., & Ahrén, B. (2004) · Diabetes · doi:10.2337/diabetes.53.suppl_3.s215 · Cited by 1,026
Insulin Degradation: Progress and Potential*
Duckworth, W. C., Bennett, R. G., & Hamel, F. G. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.5.0349 · Cited by 871
Evaluating the glucose tolerance test in mice
Andrikopoulos, S., Blair, A. R., Deluca, N., Fam, B. C., & Proietto, J. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90617.2008 · Cited by 819
Stella, V. J., & He, Q. (2008) · Toxicologic Pathology · doi:10.1177/0192623307310945 · Cited by 700
Glucagonocentric restructuring of diabetes: A pathophysiologic and therapeutic makeover
Unger, R. H., & Cherrington, A. D. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60016 · Cited by 670
Gelling, R. W., Du, X. Q., Dichmann, D. S., Rømer, J., Huang, H., Cui, L., Obici, S., Tang, B., Holst, J. J., Fledelius, C., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0237106100 · Cited by 563
Self-citationDNA-Templated Organic Synthesis and Selection of a Library of Macrocycles
Gartner, Z. J., Tse, B. N., Grubina, R., Doyon, J. B., Snyder, T. M., & Liu, D. R. (2004) · Science · doi:10.1126/science.1102629 · Cited by 503
Self-citationStructures of human insulin-degrading enzyme reveal a new substrate recognition mechanism
Shen, Y., Joachimiak, A., Rich Rosner, M., & Tang, W.-J. (2006) · Nature · doi:10.1038/nature05143 · Cited by 375
Self-citationAmyloid β-degrading cryptidases: insulin degrading enzyme, presequence peptidase, and neprilysin
Malito, E., Hulse, R. E., & Tang, W.-J. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8112-4 · Cited by 176
Self-citationEmerging combinatorial hormone therapies for the treatment of obesity and T2DM
Sadry, S. A., & Drucker, D. J. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.47 · Cited by 174
Degradation of Amylin by Insulin-degrading Enzyme
Bennett, R. G., Duckworth, W. C., & Hamel, F. G. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006170200 · Cited by 170
Drug Therapy of Postprandial Hyperglycaemia
Mooradian, A. D., & Thurman, J. E. (1999) · Drugs · doi:10.2165/00003495-199957010-00003 · Cited by 162
Tse, B. N., Snyder, T. M., Shen, Y., & Liu, D. R. (2008) · Journal of the American Chemical Society · doi:10.1021/ja805649f · Cited by 156
Self-citationMIRSKY, I. A., & Broh-Kahn, R. H. (1949) · PubMed · Cited by 126
Abdul‐Hay, S. O., Kang, D., McBride, M., Li, L., Zhao, J., & Leissring, M. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020818 · Cited by 125
Self-citationDesigned Inhibitors of Insulin-Degrading Enzyme Regulate the Catabolism and Activity of Insulin
Leissring, M. A., Malito, E., Hédouin, S., Reinstatler, L. S., Sahara, T., Abdul‐Hay, S. O., Choudhry, S., Maharvi, G. M., Fauq, A. H., Huzarska, M. A., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010504 · Cited by 114
Self-citationManolopoulou, M., Guo, Q., Malito, E., Schilling, A. B., & Tang, W. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m900068200 · Cited by 114
Self-citationEmerging Therapies Mimicking the Effects of Amylin and Glucagon-Like Peptide 1
Riddle, M. C., & Drucker, D. J. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1267 · Cited by 113
Insulin and Glucagon Degradation by the Same Enzyme
Duckworth, W. C., & Kitabchi, A. E. (1974) · Diabetes · doi:10.2337/diab.23.6.536 · Cited by 95
Malito, E., Ralat, L. A., Manolopoulou, M., Tsay, J. L., Wadlington, N. L., & Tang, W. (2008) · Biochemistry · doi:10.1021/bi801192h · Cited by 92
Self-citationGedulin, B. R., Jodka, C. M., Herrmann, K., & Young, A. A. (2006) · Regulatory Peptides · doi:10.1016/j.regpep.2006.06.004 · Cited by 81
Peptidomics approach to elucidate the proteolytic regulation of bioactive peptides
Kim, Y., Lone, A. M., Nolte, W. M., & Saghatelian, A. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1203195109 · Cited by 50
Self-citationÅhrén, B., Winzell, M. S., & Pacini, G. (2008) · Journal of Endocrinology · doi:10.1677/joe-07-0460 · Cited by 38
Cited by
DNA-encoded chemistry: enabling the deeper sampling of chemical space
Goodnow, R. A., Dumelin, C. E., & Keefe, A. D. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.213 · Cited by 621
Kamalam, B. S., Medale, F., & Panserat, S. (2017) · Aquaculture · doi:10.1016/j.aquaculture.2016.02.007 · Cited by 581
New Modalities for Challenging Targets in Drug Discovery
Valeur, E., Guéret, S. M., Adihou, H., Gopalakrishnan, R., Lemurell, M., Waldmann, H., Grossmann, T. N., & Plowright, A. T. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201611914 · Cited by 382
E3 Ligase Ligands for PROTACs: How They Were Found and How to Discover New Ones
Ishida, T., & Ciulli, A. (2021) · SLAS Discovery · doi:10.1177/2472555220965528 · Cited by 380
Neri, D., & Lerner, R. A. (2018) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-062917-012550 · Cited by 364
“For example, David Liu and collaborators reported the isolation of a 50 nM inhibitor of Insulin Degrading Enzyme (IDE), from a library of 13,824 macrocycles, constructed using a DNAtemplated synthesis approach (86) [Figure 9j].”
Method
Metadata
- Authors
- Maianti, J. P., McFedries, A., Foda, Z. H., Kleiner, R. E., Du, X. Q., Leissring, M. A., Tang, W.-J., Charron, M. J., Seeliger, M. A., Saghatelian, A., & Liu, D. R.
- Venue
- Nature
- Published
- 2014-05-21
- Volume
- 511
- Issue
- 7507
- Pages
- 94-98
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2048361834
- Cited by
- 254
- References
- 27
- FWCI
- 20.11
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.